Author： Watts D. Heather
Publisher： Adis International
ISSN： 0114-5916
Source： Drug Safety, Vol.29, Iss.6, 2006-01, pp. : 467-490
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Treating Mood Disorders During Pregnancy: Safety Considerations
Drug Safety, Vol. 28, Iss. 8, 2005-01 ,pp. :
Access to resources
Recommend
Treating Inflammatory Bowel Disease During Pregnancy: Risks and Safety of Drug Therapy
Drug Safety, Vol. 21, Iss. 4, 1999-10 ,pp. :
Treating Allergic Rhinitis in Pregnancy: Safety Considerations
By Mazzotta P. Loebstein R. Koren G.
Drug Safety, Vol. 20, Iss. 4, 1999-04 ,pp. :
Tacrolimus formulations: UK MHRA issues safety update
Reactions Weekly, Vol. 1, Iss. 1236, 2009-01 ,pp. :
Health Canada issues safety update for tinzaparin sodium
Reactions Weekly, Vol. 1, Iss. 1325, 2010-01 ,pp. :